Duane H. Bartelt

Papers

Total Citations

201

H-Index

About

Duane H. Bartelt has made foundational contributions to cancer cytogenetics, particularly in the characterization of renal and ovarian tumors. His landmark 1992 study, cited over 120 times, provided the first comprehensive cytogenetic analysis of renal oncocytomas and chromophobe cell renal carcinoma, establishing key chromosomal markers that distinguish these subtypes and advancing the molecular classification of kidney cancers. Bartelt further extended this expertise to gynecologic oncology, with his 1993 work on epithelial ovarian carcinoma—cited nearly 80 times—helping to define recurrent chromosomal aberrations in this aggressive disease. His research has been instrumental in linking specific cytogenetic abnormalities to tumor behavior, aiding both diagnosis and the development of targeted therapies. Through these studies, Bartelt has shaped our understanding of how chromosomal changes drive cancer progression, leaving a lasting impact on the fields of urologic and gynecologic pathology. His work remains a critical reference for researchers exploring the genetic underpinnings of these malignancies.